These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 174229)

  • 1. Observations on the mechanism of 99mTc-labeled phosphate complex uptake in metabolic bone disease.
    Rosenthall L; Kaye M
    Semin Nucl Med; 1976 Jan; 6(1):59-67. PubMed ID: 174229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between bone uptake of 99mTc-pyrophosphate and hydroxyproline in blood and urine.
    Wiegmann T; Kirsh J; Rosenthall L; Kaye M
    J Nucl Med; 1976 Aug; 17(8):711-4. PubMed ID: 180269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
    Kaye M; Silverton S; Rosenthall L
    J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease.
    Rosenthall L; Kaye M
    J Nucl Med; 1975 Jan; 16(1):33-9. PubMed ID: 162946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen heterogeneity within different growth regions of long bones of rachitic and non-rachitic chicks.
    Toole BP; Kang AH; Trelstad RL; Gross J
    Biochem J; 1972 May; 127(4):715-20. PubMed ID: 4651137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium metabolism--recent advances.
    Raisz LG
    Dis Mon; 1972 Dec; ():1-56. PubMed ID: 4264562
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal 99mTechnetium-tin-pyrophosphate bone scans in chronic renal failure.
    Lien JW; Wiegmann T; Rosenthall L; Kaye M
    Clin Nephrol; 1976 Dec; 6(6):509-12. PubMed ID: 188582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
    Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
    Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone scanning: radionuclidic reaction mechanisms.
    Jones AG; Francis MD; Davis MA
    Semin Nucl Med; 1976 Jan; 6(1):3-18. PubMed ID: 174228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and in-vivo-distribution of different 99mTc-Sn-pyrophosphate complexes.
    Schümichen C; Roth KH; Hoffmann G
    Nucl Med (Stuttg); 1975 Dec; 14(4):323-9. PubMed ID: 2905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-Sn-pyrophosphate pharmaco-kinetics and bone image changes in parathyroid disease.
    Krishnamurthy GT; Brickman AS; Blahd WH
    J Nucl Med; 1977 Mar; 18(3):236-42. PubMed ID: 190364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.
    de Graaf P; te Velde J; Pauwels EK; Schicht IM; Kleiverda K; de Graeff J
    Eur J Nucl Med; 1982; 7(4):152-4. PubMed ID: 7075618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia.
    Vanherweghem JL; Dhaene M; Tielemans C; Dratwa M; Verbanck P; Bergmann P; Schoutens A; Fuss M
    Proc Eur Dial Transplant Assoc; 1981; 18():648-51. PubMed ID: 6276883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by estradiol-17 beta of the lathyritic effect of beta-aminopropionitrile (BAPN) on skin and bone collagen.
    Henneman DH
    Clin Orthop Relat Res; 1972; 83():245-54. PubMed ID: 5014818
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on matrix proteins of normal and lathyritic rat bone and dentine.
    Carmichael DJ; Dodd CM; Nawrot CF
    Calcif Tissue Res; 1974 Mar; 14(3):177-94. PubMed ID: 4843787
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C
    Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of a lathyrogenic agent on the synthesis and degradation of mouse bone collagen in tissue culture.
    Golub L; Stern B; Glimcher M; Goldhaber P
    Arch Oral Biol; 1968 Nov; 13(11):1395-8. PubMed ID: 5250466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.